Skip Navigation

European Heart Journal 2000 21(22):1812-1814; doi:10.1053/euhj.2000.2276
Copyright © 2000 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Yu, P.H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, P.H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorial

Semicarbazide-sensitive amine oxidase and mortality in chronic heart failure

P.H. Yu

Neuropsychiatry Research Unit, University of Saskatchewan, Saskatoon, Canada

References

  1. Boomsma F, de Kam PJ, Tjeerdsama G. Plasma semicarbazide-sensitive amine oxidase (SSAO) is an independent prognostic marker for mortality in chronic heart failure. Eur Heart J. 2000;21:1859–1863[Abstract/Free Full Text]
  2. Yu PH. Deamination of methylamine and angiopathy; toxicity of formaldehyde, oxidative stress and relevance to protein glycoxidation in diabetes. J Neural Transm. 1997;52:201–216
  3. Enrique-Tarancon G, Marti L, Morin N. Role of semicarbazide-sensitive amine oxidase on glucose transport and GLUT4 recruitment to the cell surface in adipose cells. J Biol Chem. 1998;273:8025–8032[Abstract/Free Full Text]
  4. Langford SD, Trent MB, Balakumaran A, Boor PJ. Developmental vasculotoxicity associated with inhibition of semicarbazide-sensitive amine oxidase. Toxicol Appl Pharmacol. 1999;155:237–254[CrossRef][ISI][Medline]
  5. Smith DJ, Salmi M, Bono P, Hellman J, Leu T, Jalkanen S. Cloning of vascular adhesion protein a; Reveals a novel multifunctional adhesion molecule. J Exp Med. 1998;188:17–27[Abstract/Free Full Text]
  6. Kurkijarvi R, Adams DH, Leino R, Mottonen T, Jalkanen S, Salmi M. Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases. J Immunol. 1998;161:1549–1557[Abstract/Free Full Text]
  7. Boor PJ, Hysmith RM. Allylamine cardiovascular toxicity. Toxicology. 1987;44:129–144[CrossRef][ISI][Medline]
  8. Yu PH, Zuo DM. Methylamine, a potential endogenous toxin for vascular tissues: formation of formaldehyde via enzymatic deamination and the cytotoxic effects on endothelial cells. Diabetes. 1993;42:594–603[Abstract]
  9. Lo TWC, Westwood ME, McLellan AC, Selwood T, Thornalley PJ. Binding and modification of proteins by methylglyoxal under physiological conditions. J Biol Chem. 1994;269:32299–32305[Abstract/Free Full Text]
  10. Nilsson SE, Tryding N, Tufvesson G. Serum monoamine oxidase in diabetes mellitus and some other internal diseases. Acta Med Scand. 1968;184:105–108[Medline]
  11. Boomsma F, Derks FHM, van den Meiracker AH, Man in'tVeld A, Schalekamp MADH. Plasma semicarbazide-sentive amine oxidase activity is elevated in diabetes mellitus and correlates with glycosylated haemolglobin. Clin Sci. 1995;88:675–679[Medline]
  12. Mészáros Z, Szombathy T, Raimondi L, Karadi I, Romics L, Magyar K. Elevated serum semicarbazide-sensitive amine oxidase activity in non-insulin-dependent diabetes mellitus: correlation with BMI and serum triglyceride. Metabolism Clin And Exp. 1999;48:113–117
  13. Garpenstrand H, Ekblom J, Bäcklund LB, Oreland L, Rosenqvist U. Elevated plasma semicarbazide-sensitive amine oxidase (SSAO) activity in Type 2 diabetes mellitus complicated by retinopathy. Diabetic Med. 1999;16:514–521[CrossRef][ISI][Medline]
  14. Boomsma F, van Veldhuisen DJ, de Kam PJ, in't Veld AJM, Mosterd A, Lie KI. Schalekamp MADH. Plasma semicarbazide-sensitive amine oxidase is elevated in patients with congestive heart failure. Cardiovasc Res. 1997;33:387–391[Abstract/Free Full Text]
  15. Yu PH, Deng YL. Endogenous formaldehyde and vulnerability of atherosclerosis: Involvement of semicarbazide-sensitive amine oxidase-mediated methylamine turnover. Atherosclerosis. 1999;140:357–363

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Yu, P.H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, P.H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?